INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
SA

Schayowitz Adam

EVP, Head of R&DCIK 0002127119

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 1
Max Insider Score35
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SA
Schayowitz AdamDirector
FTHFaeth Therapeutics, Inc.
Grant or award
A—
25.0K sh
Oct 23, 2026Oct 27, 2026
traded Oct 23, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Faeth Therapeutics, Inc.Director · Oct 27, 2026
  • Insider ofevidence
    Zymeworks Inc.EVP, Head of R&D · Oct 9, 2026
9
SA
Schayowitz AdamEVP, Head of R&D
ZYMEZymeworks Inc.
Option exercise
M
—
37.0K sh
Oct 9, 2026
Oct 9, 2026
traded Oct 9, 2026
+0d
SEC FORM 4

Evidence

35
SA
Schayowitz AdamEVP, Head of R&D
ZYMEZymeworks Inc.
Open-market sale
SELL$358K
13.8K sh
Oct 9, 2026Oct 9, 2026
traded Oct 9, 2026
+0dSEC FORM 4

Evidence

21
SA
Schayowitz AdamEVP, Head of R&D
ZYMEZymeworks Inc.
Option exercise
M—
37.0K sh
Oct 9, 2026Oct 9, 2026
traded Oct 9, 2026
+0dSEC FORM 4

Evidence